|
|
Article: Study highlights benefits of drug-eluting stents in coronary revascularization.
- Article from:
- Medical Devices & Surgical Technology Week
- Article date:
- September 5, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 SEP 5 - (NewsRx.com & NewsRx.net) -- A pooled analysis of 11 previously published trials provides evidence that drug-eluting stents (DES) - increasingly used in coronary angioplasty - have benefits over bare-metal stents (BMS) by reducing the need for later revascularization and reducing the risk of cardiac events. However, the study did not find that the use of DES reduced the risk of death or heart attack compared with BMS.
Stents are small wire-mesh tubes positioned in the coronary artery after balloon angioplasty to help widen the artery, thereby increasing blood flow to the heart. A potential complication of stenting is the reaction from cells in the ...